These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 19879523

  • 1. A curious case of anti-D antibody titer.
    Hensley JG, Coughlin KP, Klein LL.
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [Abstract] [Full Text] [Related]

  • 2. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report.
    Seeho SK, Burton G, Leigh D, Marshall JT, Persson JW, Morris JM.
    Hum Reprod; 2005 Mar; 20(3):697-701. PubMed ID: 15661826
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL, Li N, Li BJ, Peng JY, Shu XW, Yu YY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND.
    Methods Mol Biol; 2008 Mar; 444():185-201. PubMed ID: 18425481
    [Abstract] [Full Text] [Related]

  • 7. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ, Greiss MA.
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K, Martin P, Daniels G.
    Methods Mol Biol; 2009 Mar; 496():143-57. PubMed ID: 18839110
    [Abstract] [Full Text] [Related]

  • 10. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J, Tappenden P, Lloyd Jones M, Wight J, Forman K, Wray J, Beverley C.
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [Abstract] [Full Text] [Related]

  • 11. Non-invasive prenatal diagnosis and determination of fetal Rh status.
    van der Schoot CE, Hahn S, Chitty LS.
    Semin Fetal Neonatal Med; 2008 Apr; 13(2):63-8. PubMed ID: 18249590
    [Abstract] [Full Text] [Related]

  • 12. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ.
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [Abstract] [Full Text] [Related]

  • 13. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M, Nakanishi K, Kaku S, Moro H, Hodohara K, Aotani H, Takebayashi K, Noda Y.
    Fetal Diagn Ther; 2004 Aug; 19(2):182-6. PubMed ID: 14764967
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The importance of laboratory diagnosis in allo-immunization through pregnancy and hemolytic disease of the newborn].
    Florea DP.
    Rev Med Chir Soc Med Nat Iasi; 2010 Aug; 114(1):211-3. PubMed ID: 20509304
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.
    Bianchi DW, Avent ND, Costa JM, van der Schoot CE.
    Obstet Gynecol; 2005 Oct; 106(4):841-4. PubMed ID: 16199645
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.